The largest database of trusted experimental protocols

Cb17 prkdcscid j mice

Manufactured by Jackson ImmunoResearch
Sourced in Montenegro

The CB17-Prkdcscid/J mouse is a strain of immunodeficient mice that lack functional B and T cells. This mouse model is commonly used in research to study immune system function and development, as well as for the evaluation of therapeutics and the xenografting of human cells and tissues.

Automatically generated - may contain errors

10 protocols using cb17 prkdcscid j mice

1

Prostate Tumor Xenograft Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
LNCap prostate tumor xenografts were created by the subcutaneous injection of 1 × 107 cells into the right flank of 6–8 week old male NOD.CB17-PrkdcSCID/J mice (Jackson Laboratories, Bar Harbor, ME). PC-3 prostate tumor xenografts were generated by subcutaneously injecting 6–8 week old male NOD.CB17-PrkdcSCID/J mice with 2 × 106 cells in the right flank. Injections of both LNCaP and PC-3 cell lines were performed in a 50:50 mixture of PBS and Matrigel in a total volume of 100 μL. Mice were monitored for tumor growth over time, and all subsequent studies were initiated when tumors reached an average volume of 100 mm3 as determined by caliper measurements. All animal experiments were done in accordance with protocols approved by the Institutional Animal Care and Use Committee of Memorial Sloan Kettering Cancer Center and NIH guidelines for animal welfare were followed.
+ Open protocol
+ Expand
2

Prostate Tumor Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 4-week-old male NOD.CB17-Prkdcscid/J mice were purchased from the Jackson Laboratory (Bar Harbor, MI, USA). All animal procedures were verified and approved by the Institutional Animal care and Use Committee of UTMDACC. To study primary prostate tumor formation, 2 × 106 RFP–luciferase-labeled DU145 cells were injected s.c. on both the flanks of 6-week-old male NOD/SCID mice. Once palpable tumors were discernable, tumor-bearing mice were randomly segregated into four groups, and drug treatment was initiated every 24 h for 5 days per week. SB203580 (0.2 μmol in 100 μl per ~20 g mouse), Enzalutamide (10 mg/kg) or a combination of both drugs (or vehicle) were administered s.c., and tumor growth was assessed as described previously.17 (link) Investigators were blinded to the group allocation while assessing experimental outcomes. At the end of the treatment period, tumors were excised, average diameter calculated using calipers and tumor weight noted. Tumors were then processed for RNA isolation and/or fixed in formalin, paraffin-embedded, sectioned and stained with hematoxylin/eosin and pATF2, AR and FOXC2 antibodies.
+ Open protocol
+ Expand
3

Xenograft of Kidney Organoids and Teratomas

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kidney organoid cultures (400,000 cells) were dissociated with accutase, pelleted, resuspended in Advanced RPMI and injected into the kidneys of P0 NOD.CB17-Prkdcscid/J mice (Jackson Labs). The mice were sutured and killed 3 weeks later and the kidneys were sectioned. To form teratomas ∼2,000,000 undifferentiated hPSCs were dissociated, resuspended in 50 μl cold Matrigel (BD), and injected dorsally into 8-week-old NOD.CB17-Prkdcscid/J mice. Growths were collected 8–10 weeks later. Male and female animals were used. Experiments were performed in compliance with ethical regulations and ARRIVE guidelines and in accordance with protocols approved by the Harvard Medical Area Standing Committee on Animals.
+ Open protocol
+ Expand
4

Bioluminescent Tumor Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female BALB/c and SCID CB17-Prkdcscid/J mice (age 6–8 weeks) were purchased from Jackson Laboratories, and maintained according to the IUCAC Guidelines of Emory. 4T1, a BALB/c mouse breast cancer cell line was obtained from ATCC (Manassas, VA). The protocol was approved by the committee on the Ethics of animal Experiments of the University of Emory (Permit number: A3180-01). Stably transfected luciferase-expressing 4T1 was a gift of Dr. Lili Yang. 4T1 cell lines were cultured in RPMI 1640 (Life Technologies, Grand Island, NY) and Dulbecco's modified Eagle's medium (DMEM/hi glucose) supplemented with 10% fetal bovine serum enriched with 0.4 mmol/L of sodium pyruvate, and antibiotics (penicillin, streptomycin), respectively. Female BALB/c or SCID mice were injected subcutaneously in the left 1rd mammary fat pad with 1 × 106 cells viable 4T1 tumor cells in 100 μL phosphate-buffered saline (PBS). Mice were monitored every other day to evaluate tumor growth. Treatment of tumor-bearing mice began when tumor growth was confirmed with BLI.
+ Open protocol
+ Expand
5

Allogeneic Skin Transplantation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Donor ear or tail skin was taken from BalbC mice and transplanted onto the backs of recipient C57bl6 or NOD.CB17-Prkdc scid/J mice purchased from Jackson Laboratories (stock #000664, #001303 respectively). Mice (8 weeks, 25g) were housed in a pathogen-free facility at Arkansas Children’s Research Institute. All protocols were approved by the Institutional Animal Care and Use Committee.
+ Open protocol
+ Expand
6

Kidney Organoids and Teratoma Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kidney organoid cultures (400,000 cells) were dissociated with Accutase, pelleted, resuspended in Advanced RPMI, and injected into the kidneys of P0 NOD.CB17-Prkdcscid/J mice (Jackson Labs). The mice were sutured and sacrificed three weeks later and the kidneys were sectioned. To form teratomas, ∼ 2,000,000 undifferentiated hPSCs were dissociated, resuspended in 50 µl cold Matrigel (BD), and injected dorsally into 8-week old NOD.CB17-Prkdcscid/J mice. Growths were harvested 8–10 weeks later. Male and female animals were utilized. Experiments were performed in compliance with ethical regulations and ARRIVE guidelines and in accordance with protocols approved by the Harvard Medical Area Standing Committee on Animals.
+ Open protocol
+ Expand
7

NOD.CB17-Prkdcscid/J Mouse Tumor Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
8 week old NOD.CB17-Prkdcscid/J mice (Jackson Labs) were injected with 100μL PBS cell suspension using E1KD shScr, E1KD shILEI or E1KD shLIFR cells at 1,000, 10,000 or 100,000 cells per fat pad. Mice were evaluated weekly using calipers to assess tumor volume. Mice were sacrificed and tumors and lungs were extracted at 13–14 weeks. Final tumor volumes were weighed and lungs were stained for H&E. Briefly, lungs were formalin-fixed and paraffin-embedded in the Biorepository and Tissue Analysis Core at MUSC. Paraffin-embedded lungs were cut into 5 μm sections and stained with hematoxylin and eosin. H&E stained lungs were imaged using a 1.25x objective on an Olympus BX61 Microscope with an Olympus DP72 8-bit RGB camera and Cellsens software in the Laboratory Core in the Center for Oral Health Research at MUSC. Two-way Anova statistical analysis for volume measurements over time and Student t-test analysis of final tumor weights and metastatic tumor burden were performed using Prism 7 (Graphpad).
+ Open protocol
+ Expand
8

Biodistribution of Radiolabeled Trastuzumab

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal studies were performed under guidelines established by the Duke University Institutional Animal Care and Use Committee. To augment tumor growth, 60-day continuous release 17-β-estradiol pellets (Innovative Research of America, Sarasota, FL) were implanted on the back of 10–12 week old female NOD.CB17-Prkdcscid/J mice (Jackson Laboratories, Bar Harbor, ME). Two days later, mice were inoculated in the flank with 5 × 106 BT474M1 cells in 50 % Matrigel (BD Biosciences, Bedford, MA). Biodistribution studies were initiated when tumors reached a volume of 350–500 mm3. Six groups of 5 mice were injected via the tail vein with 1.1 μCi (0.8 μg) of trastuzumab-NHS-[131I]IB-d-EEEG and 5 μCi (0.8 μg) of trastuzumab-Mal-d-GEEEK-[125I]IB. At 4, 12, 24, 48, 96 and 144 h post injection, mice were euthanized by isofluorane overdose, dissected, and organs isolated. Blot-dried tissues of interest were weighed and counted for 125I and 131I radioactivity along with injection standards in a dual-channel gamma counter. Results were expressed as percentage of injected dose per gram of tissue (%ID/g), except for thyroid for which %ID/organ values was determined. Tumor-to-tissue ratios also were calculated.
+ Open protocol
+ Expand
9

NOD.CB17-Prkdcscid/J Mouse Tumor Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
8 week old NOD.CB17-Prkdcscid/J mice (Jackson Labs) were injected with 100μL PBS cell suspension using E1KD shScr, E1KD shILEI or E1KD shLIFR cells at 1,000, 10,000 or 100,000 cells per fat pad. Mice were evaluated weekly using calipers to assess tumor volume. Mice were sacrificed and tumors and lungs were extracted at 13–14 weeks. Final tumor volumes were weighed and lungs were stained for H&E. Briefly, lungs were formalin-fixed and paraffin-embedded in the Biorepository and Tissue Analysis Core at MUSC. Paraffin-embedded lungs were cut into 5 μm sections and stained with hematoxylin and eosin. H&E stained lungs were imaged using a 1.25x objective on an Olympus BX61 Microscope with an Olympus DP72 8-bit RGB camera and Cellsens software in the Laboratory Core in the Center for Oral Health Research at MUSC. Two-way Anova statistical analysis for volume measurements over time and Student t-test analysis of final tumor weights and metastatic tumor burden were performed using Prism 7 (Graphpad).
+ Open protocol
+ Expand
10

Xenograft Model of TNBC Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female NOD.CB17-Prkdcscid/J mice (Jackson Laboratories) were housed in pathogen-free rodent facilities at NYU Langone Health. All supplies (cages, chow, and sterile water) were autoclaved, and mice were housed in sterile conditions within high-efficiency particulate arrestance filtered micro-isolators and fed with irradiated food and acidified water. All experiments were conducted according to standard protocols outlined by the University Committee on the Use and Care of Animals. 1x106 SUM149PT or olaparib-resistant clone cell lines were injected into the mammary fat pads of 6- to 8-week-old female mice. Olaparib (25 mg/kg) was administrated daily via intraperitoneal injection, and doxycycline (2 g/Kg) was administrated in the food. Tumors were monitored weekly and animals were euthanized by the end of treatment or when the tumors reached an average of 1000 mm3. Tumor volume was calculated using the following equation: volume = 0.5 × (L × W2), where L = length and W = width. All mice that reached the endpoint of the experiment were euthanized and tumors excised, weighed and proteins extracts prepared for immunoblotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!